Why Is There a 2027 Part D Premium Increase?

Why Are Stand-Alone Part D Premiums Rising for 2027?

If you have recently opened your annual renewal letter and noticed a higher monthly bill for your prescription drug coverage, you are not alone. Across the country, Medicare beneficiaries are asking the same question: why is there a 2027 Part D premium increase? The short answer is that the landscape of Medicare prescription drug coverage is undergoing a massive financial shift. While the benefits for seniors have generally improved—thanks to strict new limits on how much you can spend out of your own pocket—the underlying costs to provide that insurance have skyrocketed.

For 2027, the national base beneficiary premium increased to $41.33, up from $38.99 in 2026. This represents a 6% increase, which is the maximum annual jump allowed for the base premium under the Inflation Reduction Act. However, this 6% cap only applies to the mathematical baseline the government uses, not the actual sticker price of the stand-alone drug plans sold by private insurance companies. Many seniors are seeing their actual monthly premiums rise by a much larger percentage.

To understand why your specific plan might be getting more expensive, we have to look behind the scenes at how Medicare Part D is funded. The 2027 Part D premium increase is primarily driven by three major factors: the end of a massive federal subsidy program, insurers taking on more financial liability for catastrophic drug costs, and the rising popularity of incredibly expensive specialty medications. In this guide, we will break down exactly how these legislative mechanics impact your wallet and what you can do to protect your budget.

The End of the $9.8 Billion Federal Stabilization Subsidy

To understand the 2027 premium hikes, we first need to look at what kept prices artificially low in 2025 and 2026. When the Inflation Reduction Act was passed, it introduced sweeping changes to Medicare Part D, including capping out-of-pocket costs and eliminating the coverage gap (often called the donut hole). While these changes were fantastic news for seniors who take expensive medications, the federal government knew these new rules would cost insurance companies billions of dollars.

To prevent insurers from immediately doubling or tripling premiums to cover these new expenses, the Centers for Medicare and Medicaid Services (CMS) created a temporary buffer. They launched a premium stabilization demonstration program, injecting $9.8 billion in federal subsidies into the Part D market for 2025 and 2026. This money was paid directly to insurance companies to help them absorb the shock of the new rules without passing the costs onto you.

However, that temporary pilot program officially ended on December 31, 2026. With the federal subsidies gone, insurance companies are now bearing the full brunt of the new Part D benefit structure. Without the government artificially suppressing prices, plans are forced to pass their true operating costs onto consumers for 2027. This sudden removal of federal funds is the single largest reason you are seeing a 2027 Part D premium increase.

How the $2,400 Out-of-Pocket Cap Impacts Insurer Costs

The second major driver of the 2027 Part D premium increase is the permanent redesign of the Medicare Part D benefit structure. For 2027, the maximum out-of-pocket (OOP) limit for covered Part D drugs is $2,400. Once your true out-of-pocket costs hit this $2,400 cap, you pay $0 for your covered medications for the rest of the calendar year. You can learn more about the mechanics of this limit in our guide on the Medicare Part D out of pocket cap.

While a $2,400 cap is a tremendous relief for beneficiaries who require expensive treatments for conditions like cancer, multiple sclerosis, or rheumatoid arthritis, it completely changes the math for insurance companies. Before these reforms, the federal government paid the vast majority of a beneficiary's drug costs once they reached the catastrophic coverage phase. Now, the liability has flipped. Insurance companies are responsible for a much larger share of those catastrophic drug costs.

The Impact of Expensive Specialty Drugs

Adding fuel to the fire is the surging utilization of high-cost specialty medications. For example, negotiated prices for a second batch of 15 Part D drugs take effect in 2027. While Medicare negotiating prices saves the system money overall, the sheer volume of prescriptions being written for expensive drugs—particularly GLP-1 medications used for diabetes and weight management, like Ozempic and Wegovy—continues to strain plan budgets.

When an insurance company knows it will have to pay thousands of dollars a month for a single member's medication after that member hits their $2,400 cap in February or March, the insurer has to find a way to balance their budget for the rest of the year. Their primary method for doing this is raising the monthly premiums for everyone in the plan, spreading the financial risk across all members.

The Base Premium Fallacy: Why Your Bill Isn't Exactly $41.33

If you read the news, you might see headlines stating that the 2027 Medicare Part D premium is $41.33. This causes a lot of confusion when seniors open their mail and see a bill for $75, $90, or even over $100 a month. It is critical to understand the base premium fallacy.

The figure of $41.33 is the national base beneficiary premium. It is a statutory formula input used by the government. CMS uses this exact number to calculate things like the Late Enrollment Penalty and the amount of subsidies paid to low-income beneficiaries. It is not the actual sticker price of a stand-alone prescription drug plan.

Private insurance companies set their own premiums based on the specific benefits they offer, the pharmacies in their network, and the drugs on their formulary. If a plan covers a wider variety of expensive brand-name drugs, offers a broad national network of pharmacies, and has a low deductible, its premium will be significantly higher than the $41.33 base rate. Conversely, a very basic plan with a restrictive network might cost less than the base rate. Never assume your monthly bill will match the national base premium.

Comparing 2026 and 2027 Part D Deductibles

Premiums are only one part of the equation. To truly understand your drug costs for 2027, you must also look at the deductible. The deductible is the amount you must pay out of your own pocket for your medications before your insurance plan starts sharing the cost.

For 2027, the maximum standard deductible allowed by Medicare has increased. Let us look at a side-by-side comparison of the key figures between 2026 and 2027.

As the table shows, the maximum standard deductible increased from $615 in 2026 to $700 in 2027. This means that if you choose a plan with the standard deductible, you will have to pay the first $700 of your medication costs at the pharmacy counter before your plan's copays or coinsurance kick in. Some plans offer a $0 deductible, but these plans typically charge a much higher monthly premium to make up the difference.

Formulary Changes: The Hidden Threat Bigger Than Premium Hikes

While a 2027 Part D premium increase might be the most obvious change to your plan, it is rarely the most expensive one. The real hidden threat lies in the plan's formulary—the official list of medications the insurance company agrees to cover.

Because insurance companies are facing higher costs due to the $2,400 out-of-pocket cap and the end of federal subsidies, they are looking for ways to save money. If they cannot raise premiums high enough to cover their costs, they will change their formularies instead. Here are the three most common ways insurers shift costs to you through the formulary:

• Moving drugs to higher tiers: Part D plans organize drugs into tiers (usually Tiers 1 through 5). Tier 1 drugs are inexpensive generics with low copays, while Tier 4 and 5 drugs are expensive brand-name and specialty medications. For 2027, your plan might move your daily maintenance medication from a Tier 2 to a Tier 3, meaning your copay could double or triple.
• Switching from copays to coinsurance: A copay is a flat dollar amount (like $10 per refill). Coinsurance is a percentage of the drug's total cost (like 20%). If your plan switches your $300 medication from a $15 copay to a 20% coinsurance, you will suddenly pay $60 at the pharmacy counter.
• Dropping drugs entirely: Insurers have the right to remove medications from their formulary completely from one year to the next. If your drug is dropped for 2027, you will have to pay the full retail price out of pocket unless you switch to an alternative medication or file a complex exception appeal.

This is why you cannot simply look at the premium increase and decide to stay with your current plan. A plan with a low premium but a restrictive formulary could end up costing you thousands of dollars more over the course of the year.

Protected Benefits: $35 Insulin and Free Vaccines for 2027

Amidst the news of rising premiums and deductibles, there is still some good news for 2027. Certain benefits are protected by federal law and will not change, regardless of which stand-alone drug plan you choose.

First, the cost of covered insulin remains strictly capped. For 2027, you will pay no more than $35 for a one-month supply of each Medicare-covered insulin product you take. This $35 cap applies immediately, meaning you do not have to meet your $700 deductible first. If you take multiple types of insulin, each type is capped at $35 per month.

Second, all commercially available adult vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) remain at a $0 cost-sharing level. This means you can get your shingles, RSV, pneumonia, and flu vaccines completely free of charge, with no deductible or copay, as long as your Part D plan covers them.

Age vs. Income: Does Part D Cost More As You Get Older?

A common worry among seniors is that their Medicare Part D premiums are increasing simply because they are getting older. This is a myth. Medicare Part D premiums are community-rated. This means that an 85-year-old and a 65-year-old living in the same ZIP code and enrolled in the exact same drug plan will pay the exact same base premium. Your age does not trigger a 2027 Part D premium increase.

However, your income absolutely can increase your costs. If you are a higher-income earner, you are subject to the Income-Related Monthly Adjustment Amount (IRMAA). IRMAA is an extra surcharge added to your standard Part D premium.

How IRMAA is Calculated for 2027

The Social Security Administration determines if you owe an IRMAA surcharge based on your tax returns from two years prior. This means your 2027 Part D IRMAA is based on the modified adjusted gross income (MAGI) you reported on your 2025 tax return.

If your 2025 income exceeded the threshold set by Medicare, the government will automatically deduct the IRMAA surcharge from your monthly Social Security check, or bill you directly if you are not yet drawing Social Security. It is important to note that the IRMAA surcharge is paid to Medicare, not to your private insurance company. Even if you switch to a cheaper drug plan, you cannot escape the IRMAA surcharge if your income requires it.

The Risk of Dropping Part D to Avoid Higher Premiums

When faced with a steep 2027 Part D premium increase, some healthy seniors who do not currently take any prescription medications consider dropping their stand-alone drug plan entirely. They reason that paying $50 or $80 a month for coverage they do not use is a waste of money. This is one of the most dangerous financial mistakes a Medicare beneficiary can make.

Medicare Part D is designed as insurance against catastrophic future events, not just a discount card for current medications. If you drop your coverage in January because you are healthy, and then you are diagnosed with a serious illness in April that requires a $3,000-per-month medication, you cannot simply re-enroll in Part D right away. You would have to pay the full retail price for your medications entirely out of pocket until the next Annual Enrollment Period, and your coverage would not start until the following January 1st.

Furthermore, dropping your coverage will trigger a permanent financial penalty when you finally do re-enroll. The federal government strictly penalizes beneficiaries who go without creditable prescription drug coverage.

How the Lifetime Late Enrollment Penalty Accumulates

The Medicare Part D Late Enrollment Penalty (LEP) is a permanent surcharge added to your monthly premium for as long as you have Medicare drug coverage. The penalty is triggered if there is a period of 63 or more continuous days after your Initial Enrollment Period where you do not have Part D or other creditable prescription drug coverage (like from an employer or the VA).

The penalty is calculated mathematically: it is 1% of the national base beneficiary premium for every full month you went without coverage. Because the base premium increased to $41.33 for 2027, the penalty amount also increases.

The Hidden Penalty Hike

Many seniors do not realize that the penalty is a floating number, not a fixed dollar amount. If you accumulated a 50-month penalty back in 2020, you do not pay a fixed 2020 rate. You pay 50% of the current year's base premium. Therefore, anyone with an existing penalty will see their penalty amount increase in 2027, simply because the $41.33 base rate is higher than the 2026 rate.

Here is a table showing how the penalty accumulates based on the 2027 base premium of $41.33 (which equates to roughly $0.41 per penalized month):

As you can see, going five years without coverage will add nearly $25 a month to your premium for the rest of your life. This penalty is added on top of your plan's standard premium and any IRMAA surcharges you might owe. This is why it is almost always better to enroll in the lowest-premium plan available in your area just to maintain creditable coverage, rather than dropping Part D entirely.

Steps to Take During Open Enrollment Before December 7

The best way to fight back against a 2027 Part D premium increase is to actively shop your coverage during the Annual Enrollment Period (AEP). The AEP is currently open from October 15 to December 7, 2026. Any changes you make during this window will take effect on January 1, 2027. If you miss this window, you may be locked into an expensive plan for the entire year. You can read more about what happens if you missed the Medicare open enrollment deadline.

Do not let inertia cost you money. Follow this checklist to ensure you have the most cost-effective plan for 2027:

1. Read your Annual Notice of Change (ANOC): Your current insurer mailed this document to you in September. It clearly lists your 2027 premium, your new deductible, and any changes to the formulary. Read it carefully.
2. Make a list of your current medications: Write down the exact name, dosage, and frequency of every prescription drug you take. Be sure to note if you require a brand-name drug or if a generic is acceptable.
3. Check the 2027 formulary: Do not just look at the premium. Verify that every drug on your list is covered on your plan's 2027 formulary, and check which tier each drug is placed in.
4. Verify your preferred pharmacy: Insurance companies frequently change their preferred pharmacy networks. A pharmacy that offered preferred pricing in 2026 might be out-of-network or standard-tier in 2027, drastically increasing your copays.
5. Consider the Medicare Prescription Payment Plan: If you expect to hit the $2,400 out-of-pocket cap early in the year, look into this new program that allows you to smooth your out-of-pocket costs into monthly installments. Read our guide to see is the Medicare Prescription Payment Plan worth it.

How to Compare 2027 Stand-Alone Drug Plans in Your ZIP Code

The expiration of the $9.8 billion stabilization subsidy and the shift in catastrophic liability mean the 2027 Part D premium increase is unavoidable for many plans. However, that does not mean you have to accept the first price your current insurer offers you. Because private insurance companies compete for your business, prices for stand-alone drug plans vary wildly from one company to the next, even within the same ZIP code.

The smartest move you can make is to compare all the available options in your area before the December 7 deadline. At Genie Medicare, we make granting your Medicare rate wish incredibly easy. You can compare Part D Drug Plans rates in about 30 seconds. We believe in transparency, which means you see real prices first—no name, phone number, or email address is needed to view your options.

If you find a plan that fits your budget and covers your medications, or if you simply want a second opinion to make sure you are not overpaying, our licensed agents are ready to help. You can compare Part D Drug Plans rates right now, entirely for free, and secure the best possible coverage for 2027.